| |
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910809498803321 |
|
|
Autore |
McCaughan Geoffrey W |
|
|
Titolo |
Advanced Therapy for Hepatitis C [[electronic resource]] |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
|
|
|
|
ISBN |
|
1-283-28323-9 |
9786613283238 |
1-4443-4634-2 |
1-4443-4631-8 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (233 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
McHutchisonJohn |
PawlotskyJean-Michel |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Antiviral agents |
Antiviral Agents - therapeutic use |
Antiviral Agents -- therapeutic use |
Hepatitis C - therapy |
Hepatitis C -- therapy |
Hepatitis C - Treatment |
Hepatitis C -- Treatment |
Hepatitis, Viral, Human |
Flaviviridae Infections |
Anti-Infective Agents |
RNA Virus Infections |
Therapeutic Uses |
Virus Diseases |
Hepatitis |
Diseases |
Liver Diseases |
Pharmacologic Actions |
Chemical Actions and Uses |
Digestive System Diseases |
Antiviral Agents |
Hepatitis C |
Medicine |
Health & Biological Sciences |
Gastroenterology |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
Advanced Therapy for Hepatitis C; Contents; Contributors; Preface; Section I Foundations for Understanding Antiviral Therapies in HCV; 1 HCV Replication; 2 Hepatitis C Virus Genotypes; 3 Immune Responses to HCV: Implications for Therapy; 4 Mechanisms of Action of Antiviral Drugs: The Interferons; 5 Pharmacology and Mechanisms of Action of Antiviral Drugs: Ribavirin Analogs; 6 Pharmacology and Mechanisms of Action of Antiviral Drugs: Polymerase Inhibitors; 7 Pharmacology and Mechanisms of Action of Antiviral Drugs: Protease Inhibitors; 8 Measuring Antiviral Responses |
Section II Efficacy and Clinical Use of Antiviral Therapies9 Genotype 1: Standard Treatment; 10 Individually Tailored Treatment Strategies in Treatment-naìˆve Chronic Hepatitis C Genotype 1 Patients; 11 Genotype 1 Relapsers and Non-responders; 12 Standard Therapy for Genotypes 2/3; 13 Altered Dosage or Durations of Current Antiviral Therapy for HCV Genotypes 2 and 3; 14 Genotypes 2 and 3 Relapse and Non-response; 15 Hepatitis C Genotype 4 Therapy: Progress and Challenges; 16 Antivirals in Acute Hepatitis C; 17 Antivirals in Cirrhosis and Portal Hypertension |
18 Treatment of Recurrent Hepatitis C Following Liver Transplantation19 Antiviral Treatment in Chronic Hepatitis C Virus Infection with Extrahepatic Manifestations; 20 Cytopenias: How they Limit Therapy and Potential Correction; 21 The Problem of Insulin Resistance and its Effect on Therapy; 22 HIV and Hepatitis C Co-infection; 23 HCV and Racial Differences; 24 HCV and the Pediatric Population; 25 New Horizons: IL28, Direct-acting Antiviral Therapy for HCV; Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Hepatologists, both researchers and front-line clinicians, now have a comprehensive guide to the treatment of patients with the HCV virus. This book focuses mainly on the efficacy and clinical use of antiviral therapies, including the use of antivirals post liver transplantation and in the presence of the HIV virus. It also explores the foundations for understanding antiviral therapies in HCV, such as the complex pharmacology and mechanisms of antiviral drugs. A 'late-breaking information' chapter contains the most recent trial results on the latest antiviral drugs. |
|
|
|
|
|
|
|
| |